{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:35:51Z","timestamp":1783784151307,"version":"3.55.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tri-Service General Hospital, Taiwan, Republic of China","award":["TSGH-C102-178, TSGH-C103-176, TSGH-C105-169, TSGH-C106-121, TSGH-C106-149"],"award-info":[{"award-number":["TSGH-C102-178, TSGH-C103-176, TSGH-C105-169, TSGH-C106-121, TSGH-C106-149"]}]},{"name":"Tri-Service General Hospital, Taiwan, Republic of China","award":["TSGH-C106-004-006-008-S05, TSGH-C107-008-S06, TSGH-C108-007-008-S06, TSGH-C01-109017"],"award-info":[{"award-number":["TSGH-C106-004-006-008-S05, TSGH-C107-008-S06, TSGH-C108-007-008-S06, TSGH-C01-109017"]}]},{"name":"Ministry of Science and Technology, Taiwan, Republic of China","award":["MOST 105-2314-B-016-021-MY3, MOST 108-2314-B-016-005"],"award-info":[{"award-number":["MOST 105-2314-B-016-021-MY3, MOST 108-2314-B-016-005"]}]},{"name":"Kaohsiung Armed Forces General Hospital, Taiwan, Republic of China","award":["KAFGH-E-109050"],"award-info":[{"award-number":["KAFGH-E-109050"]}]},{"name":"Cardinal Tien Hospital, Taipei, Taiwan, Republic of China","award":["CTH106A-2C01"],"award-info":[{"award-number":["CTH106A-2C01"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0236101","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T17:37:18Z","timestamp":1595007438000},"page":"e0236101","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model"],"prefix":"10.1371","volume":"15","author":[{"given":"Cheng-Yu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Huei","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chih","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Kung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Shu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Chen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu-Jiun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huey-Kang","family":"Sytwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Lai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1927-7088","authenticated-orcid":true,"given":"Yuan-Wu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"pone.0236101.ref001","article-title":"STAT3- and GSK3beta-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma","author":"S Maji","year":"2018","journal-title":"Carcinogenesis"},{"key":"pone.0236101.ref002","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.oraloncology.2018.07.005","article-title":"Clinical outcomes with therapies for previously treated recurrent\/metastatic head-and-neck squamous cell carcinoma (R\/M HNSCC): A systematic literature review","volume":"84","author":"M Lala","year":"2018","journal-title":"Oral Oncol"},{"issue":"3","key":"pone.0236101.ref003","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1245\/s10434-016-5629-x","article-title":"Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b Patients","volume":"24","author":"CT Liao","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"pone.0236101.ref004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.oraloncology.2016.07.013","article-title":"Oral cancer: Deregulated molecular events and their use as biomarkers","volume":"61","author":"N Sinevici","year":"2016","journal-title":"Oral Oncol"},{"issue":"5","key":"pone.0236101.ref005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"issue":"11","key":"pone.0236101.ref006","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tem.2012.06.010","article-title":"Emerging roles of PKM2 in cell metabolism and cancer progression","volume":"23","author":"W Luo","year":"2012","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"pone.0236101.ref007","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/15384047.2015.1030551","article-title":"Overexpression of pyruvate kinase M2 associates with aggressive clinicopathological features and unfavorable prognosis in oral squamous cell carcinoma","volume":"16","author":"Y Wang","year":"2015","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"pone.0236101.ref008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102907","article-title":"The Multifarious Functions of Pyruvate Kinase M2 in Oral Cancer Cells","volume":"19","author":"M Kurihara-Shimomura","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0236101.ref009","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1073\/pnas.1311249111","article-title":"JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1alpha-mediated glucose metabolism","volume":"111","author":"HJ Wang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"pone.0236101.ref010","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1073\/pnas.1000401107","article-title":"KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation","volume":"107","author":"DA Hsia","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"pone.0236101.ref011","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1242\/dev.074138","article-title":"Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression","volume":"139","author":"A Ishimura","year":"2012","journal-title":"Development"},{"issue":"1","key":"pone.0236101.ref012","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41388-018-0414-x","article-title":"KDM8\/JMJD5 as a dual coactivator of AR and PKM2 integrates AR\/EZH2 network and tumor metabolism in CRPC","volume":"38","author":"HJ Wang","year":"2019","journal-title":"Oncogene"},{"key":"pone.0236101.ref013","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.biopha.2018.07.144","article-title":"Down-regulation of JMJD5 suppresses metastasis and induces apoptosis in oral squamous cell carcinoma by regulating p53\/NF-kappaB pathway","volume":"109","author":"Y Yao","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"pone.0236101.ref014","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10555-014-9521-5","article-title":"Role of MTA1 in head and neck cancers","volume":"33","author":"H Marzook","year":"2014","journal-title":"Cancer Metastasis Rev"},{"issue":"23","key":"pone.0236101.ref015","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1158\/0008-5472.CAN-06-3161","article-title":"Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis","volume":"66","author":"P Roepman","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"pone.0236101.ref016","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1572-0241.1998.00139.x","article-title":"Milk thistle (Silybum marianum) for the therapy of liver disease","volume":"93","author":"K Flora","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"15","key":"pone.0236101.ref017","first-page":"902","article-title":"The history of Silymarin. Contribution to the history of liver therapy","volume":"20","author":"H Schadewaldt","year":"1969","journal-title":"Med Welt"},{"issue":"11","key":"pone.0236101.ref018","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/ptr.6171","article-title":"Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases","volume":"32","author":"L Abenavoli","year":"2018","journal-title":"Phytother Res"},{"issue":"11","key":"pone.0236101.ref019","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1021\/jf703694u","article-title":"Milk thistle extracts inhibit the oxidation of low-density lipoprotein (LDL) and subsequent scavenger receptor-dependent monocyte adhesion","volume":"56","author":"S Wallace","year":"2008","journal-title":"J Agric Food Chem"},{"issue":"6","key":"pone.0236101.ref020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ctrv.2015.04.008","article-title":"Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy","volume":"41","author":"J Bosch-Barrera","year":"2015","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"pone.0236101.ref021","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1039\/C3NP70122K","article-title":"Chemistry of silybin","volume":"31","author":"D Biedermann","year":"2014","journal-title":"Nat Prod Rep"},{"issue":"1","key":"pone.0236101.ref022","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jss.2007.03.080","article-title":"Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer","volume":"143","author":"FS Hogan","year":"2007","journal-title":"J Surg Res"},{"issue":"3","key":"pone.0236101.ref023","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/onc.2008.398","article-title":"Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR\/p70S6K\/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy","volume":"28","author":"P Garcia-Maceira","year":"2009","journal-title":"Oncogene"},{"issue":"14","key":"pone.0236101.ref024","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.2174\/1871520618666180905154949","article-title":"Silimarin and Cancer","volume":"18","author":"C Liakopoulou","year":"2018","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"pone.0236101.ref025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40880-017-0217-4","article-title":"Cancer chemoprevention through dietary flavonoids: what's limiting?","volume":"36","author":"H Amawi","year":"2017","journal-title":"Chin J Cancer"},{"issue":"21\u201322","key":"pone.0236101.ref026","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.lfs.2008.03.007","article-title":"Interrelation between the inhibition of glycolytic flux by silibinin and the lowering of mitochondrial ROS production in perifused rat hepatocytes","volume":"82","author":"D Detaille","year":"2008","journal-title":"Life Sci"},{"issue":"13","key":"pone.0236101.ref027","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.2174\/1871520618666180604085612","article-title":"An Overview of Natural Plant Products in the Treatment of Hepatocellular Carcinoma","volume":"18","author":"D Rawat","year":"2018","journal-title":"Anticancer Agents Med Chem"},{"key":"pone.0236101.ref028","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.lfs.2018.10.009","article-title":"Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator","volume":"213","author":"Z Jahanafrooz","year":"2018","journal-title":"Life Sci"},{"issue":"51","key":"pone.0236101.ref029","doi-asserted-by":"crossref","first-page":"89307","DOI":"10.18632\/oncotarget.19153","article-title":"Silibinin: an old drug for hematological disorders","volume":"8","author":"H Zou","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"pone.0236101.ref030","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"H Gao","year":"2015","journal-title":"Nat Med"},{"issue":"6","key":"pone.0236101.ref031","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","article-title":"Patient-derived tumour xenografts as models for oncology drug development","volume":"9","author":"JJ Tentler","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"pone.0236101.ref032","first-page":"1","article-title":"Silibinin: a potential old drug for cancer therapy","author":"XX Zhu","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"pone.0236101.ref033","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/154405910608500303","article-title":"Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway","volume":"85","author":"PN Chen","year":"2006","journal-title":"J Dent Res"},{"issue":"6","key":"pone.0236101.ref034","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"SB Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"pone.0236101.ref035","doi-asserted-by":"crossref","first-page":"33756","DOI":"10.18632\/oncotarget.16808","article-title":"Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models","volume":"8","author":"CY Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"pone.0236101.ref036","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/hed.25554","article-title":"Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model","volume":"41","author":"CY Yang","year":"2019","journal-title":"Head Neck"},{"issue":"7","key":"pone.0236101.ref037","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.oraloncology.2008.10.007","article-title":"Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo","volume":"45","author":"YW Chen","year":"2009","journal-title":"Oral Oncol"},{"key":"pone.0236101.ref038","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.biopha.2018.11.127","article-title":"An update on Drug Repurposing: Re-written saga of the drug's fate","volume":"110","author":"HS Gns","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"pone.0236101.ref039","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jcpt.12759","article-title":"Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead","volume":"44","author":"RR Shah","year":"2019","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"pone.0236101.ref040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11684-016-0432-4","article-title":"Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization","volume":"10","author":"S Sun","year":"2016","journal-title":"Front Med"},{"issue":"3","key":"pone.0236101.ref041","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7030041","article-title":"Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field","volume":"7","author":"JA Williams","year":"2018","journal-title":"J Clin Med"},{"issue":"6","key":"pone.0236101.ref042","first-page":"688","article-title":"On the chemistry of silymarin (silybin), the active principle of the fruits from Silybum marianum (L.) Gaertn. (Carduus marianus L.)","volume":"18","author":"H Wagner","year":"1968","journal-title":"Arzneimittelforschung"},{"issue":"27","key":"pone.0236101.ref043","doi-asserted-by":"crossref","first-page":"24002","DOI":"10.18632\/oncotarget.4365","article-title":"Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas","volume":"6","author":"YC Chang","year":"2015","journal-title":"Oncotarget"},{"key":"pone.0236101.ref044","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.oraloncology.2017.05.003","article-title":"Validation of the pathological classification of lymph node metastasis for head and neck tumors according to the 8th edition of the TNM Classification of Malignant Tumors","volume":"70","author":"J Garcia","year":"2017","journal-title":"Oral Oncol"},{"key":"pone.0236101.ref045","article-title":"KDM8\/JMJD5 as a dual coactivator of AR and PKM2 integrates AR\/EZH2 network and tumor metabolism in CRPC","author":"HJ Wang","year":"2018","journal-title":"Oncogene"},{"key":"pone.0236101.ref046","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2017.04.021","article-title":"RCCD1 depletion attenuates TGF-beta-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells","volume":"400","author":"J Wu","year":"2017","journal-title":"Cancer Lett"},{"issue":"9","key":"pone.0236101.ref047","first-page":"10325","article-title":"Overexpression of histone demethylase JMJD5 promotes metastasis and indicates a poor prognosis in breast cancer","volume":"8","author":"Z Zhao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"pone.0236101.ref048","first-page":"6482","article-title":"JMJD5 is a potential oncogene for colon carcinogenesis","volume":"8","author":"R Zhang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"pone.0236101.ref049","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s10555-014-9527-z","article-title":"Clinical implications of MTA proteins in human cancer","volume":"33","author":"E Kaur","year":"2014","journal-title":"Cancer Metastasis Rev"},{"issue":"51","key":"pone.0236101.ref050","doi-asserted-by":"crossref","first-page":"12451","DOI":"10.1021\/jf300964f","article-title":"Silibinin inhibits the invasion of IL-6-stimulated colon cancer cells via selective JNK\/AP-1\/MMP-2 modulation in vitro","volume":"60","author":"CM Lin","year":"2012","journal-title":"J Agric Food Chem"},{"issue":"17","key":"pone.0236101.ref051","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1021\/jf400192v","article-title":"Silibinin inhibits tumor growth through downregulation of extracellular signal-regulated kinase and Akt in vitro and in vivo in human ovarian cancer cells","volume":"61","author":"HJ Cho","year":"2013","journal-title":"J Agric Food Chem"},{"issue":"21","key":"pone.0236101.ref052","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1080\/15384101.2016.1234548","article-title":"Depletion of JMJD5 sensitizes tumor cells to microtubule-destabilizing agents by altering microtubule stability","volume":"15","author":"J Wu","year":"2016","journal-title":"Cell Cycle"},{"issue":"9","key":"pone.0236101.ref053","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1096\/fj.201601291R","article-title":"PHD3 is a transcriptional coactivator of HIF-1alpha in nucleus pulposus cells independent of the PKM2-JMJD5 axis","volume":"31","author":"ZR Schoepflin","year":"2017","journal-title":"FASEB J"},{"issue":"41","key":"pone.0236101.ref054","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1021\/acs.jafc.8b04104","article-title":"Targeting Tumor Metabolism with Plant-Derived Natural Products: Emerging Trends in Cancer Therapy","volume":"66","author":"AR Guerra","year":"2018","journal-title":"J Agric Food Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T17:37:49Z","timestamp":1595007469000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236101"}},"subtitle":[],"editor":[{"given":"Katiucia Batista Silva","family":"Paiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0236101","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]}}}